Callan Family Office’s Exelixis EXEL Stock Holding History
Bought
Maintained
Sold
Other funds holding EXEL
FCM
Callan Family Office's EXEL Position: Q2 2026 in Review
Callan Family Office opened a new position in Exelixis (EXEL) in Q2 2026: 4,007 shares worth $218K. The stake represents ﹤0.01% of the portfolio and ranks #1117 among its holdings. This is a return to the name: Callan Family Office previously reported a position in EXEL as recently as Q4 2025.
Callan Family Office first reported a position in EXEL in Q2 2025 and has held it in 3 quarters since. The position peaked at $220K in Q2 2025. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.
- Callan Family Office held 4,007 shares of Exelixis worth $218K as of Q2 2026.
- Exelixis was a new Callan Family Office position in Q2 2026.
- Exelixis made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1117 holding.
- Callan Family Office first reported a position in Exelixis in Q2 2025 and has held it in 3 quarters since.
- Callan Family Office's Exelixis position peaked at $220K in Q2 2025.
- 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.
Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.